BioCentury | Jul 25, 2011
Clinical News

IV methamphetamine: Phase I data

...to begin a Phase IIa trial of IV methamphetamine to treat stroke before year end. Sinapis Pharma Inc....
BioCentury | Jul 5, 2010
Clinical News

Methamphetamine: Phase I started

...Sinapis began a Phase I trial to evaluate IV methamphetamine in healthy volunteers. Sinapis Pharma Inc. , Jacksonville...
BioCentury | May 31, 2010
Financial News

Sinapis Pharma completes venture financing

Sinapis Pharma Inc. , Jacksonville, Fla. Business: Neurology Date completed: 5/24/10 Type: Venture financing Raised: ND Investors: Angel investors Note: The company raised an undisclosed amount in a bridge financing. WIR Staff Neurology...
BioCentury | Nov 23, 2009
Financial News

Sinapis Pharma completes venture financing

Sinapis Pharma Inc. , Jacksonville, Fla. Business: Neurology Date completed: 11/17/09 Type: Venture financing Raised: $510,000 Investors: Angel investors WIR Staff Neurology...
Items per page:
1 - 4 of 4
BioCentury | Jul 25, 2011
Clinical News

IV methamphetamine: Phase I data

...to begin a Phase IIa trial of IV methamphetamine to treat stroke before year end. Sinapis Pharma Inc....
BioCentury | Jul 5, 2010
Clinical News

Methamphetamine: Phase I started

...Sinapis began a Phase I trial to evaluate IV methamphetamine in healthy volunteers. Sinapis Pharma Inc. , Jacksonville...
BioCentury | May 31, 2010
Financial News

Sinapis Pharma completes venture financing

Sinapis Pharma Inc. , Jacksonville, Fla. Business: Neurology Date completed: 5/24/10 Type: Venture financing Raised: ND Investors: Angel investors Note: The company raised an undisclosed amount in a bridge financing. WIR Staff Neurology...
BioCentury | Nov 23, 2009
Financial News

Sinapis Pharma completes venture financing

Sinapis Pharma Inc. , Jacksonville, Fla. Business: Neurology Date completed: 11/17/09 Type: Venture financing Raised: $510,000 Investors: Angel investors WIR Staff Neurology...
Items per page:
1 - 4 of 4